Article
Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
28 Aug 2020
Abstract excerpt
Monoclonal antibodies (mAbs) have become one of the most important classes of biopharmaceutical products, and they continue to dominate the universe of biopharmaceutical markets in terms of approval and sales. They are the most profitable single product class, where they represent six of the top ten selling drugs. At the beginning of the 1990s, an in vitro antibody selection technology known as antibody phage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
